SCIENTIFIC PAPER: THE DIABETIC FOOT - PHYSIOLOGICAL PATHOLOGY, CLINICAL APPROACH AND THERAPY
LUIGI UCCIOLI
THE DIABETIC FOOT
Physiological Pathology, Clinical Approach and...
>follow
What's New in Foot and Ankle Surgery
Evidence-Based Articles Related to Foot and Ankle Surgery: "The...
>follow
Earlier surgical correction may improve TCC recurrence rates
The well-known U.S.american journal BioMechanics publishes in...
>follow
Brasilia: International simposium of diabetic foot
International simposium of diabetic foot...
>follow
Salvatelli s.r.l
Salvatelli is a company that produces orthopaedic shoes
(Molliter)
and rehabilitative breech orthesis or post-surgery/trauma
(Optima).
Register immediately!
campo vuoto
campo vuoto
EVIVENICE 2010
Optima Molliter, will take part to:
Evivenice Course 2010 ON EXTREME VASCULAR INTERVENTIONS AND ISCHEMIC FOOT MANAGEMENT
that will be held in Venice on April, from 22 to 23, Palazzo del Casino'where all the products of Optima Line will be exposed.Evivenice 2010
Innovative approaches to diabetic foot care in Italy
Original article
Brasilia: International simposium of diabetic foot
International simposium of diabetic foot
campo vuoto
campo vuoto
Sao Paulo - Brasil, CICE 2009
The city of São Paulo (Brazil) will host the next 2009 CICE National Congress on the
Interventional Intravascular Procedures from April 22nd to April 25th (see CICE 2009 for more details).
The new Optima Projects concerning the care of the acute stage of the ischemic foot will be presented during this congress.
Los Angeles, Dfcon 2009
Also this year Salvatelli Srl. will take part to Diabetic Foot Global Congress (DFCON), that will be held in Los Angeles on March, from 19th to 21, where all the products of Optima Line will be exposed.
During the annual medical meeting, a scientific poster will be presented, showing the new multicentric study on Optima Diab that is now carryin out in twelve Italian University.
OPTIMA FREE
The new orthosis Optima Free did appear.
Optima Free is destined for postsurgical rehabilitation of the forefoot and is available in the best orthopedies and centres of rehabilitation.
Optima diab
The scientific study that has recently been carried out by the University of Pisa, Department for Endocrinology and Metabolism, Hospital Unit Metabolic Diseases and Diabetology, has proved the efficiency of the non-removable device OPTIMA in treating diabetic foot lesions. The study has been published in the well-know journal Diabetes Care in March this year. For further information: Diabetes Care
Non-Removable System
By means of a special plastic strap supplied with the product (NRS), the operator can fix Optima Diab shoe as to be non-removable. The only way the NSR can be anchored is by applying pressure, and can be removed anly by cutting it.




